instrument_fundamentals
date | Close | change | Change (%) | instr__open | High | Low |
---|
instr__news

BioNTech to Present Progress Across Diversified Oncology Pipeline at the 2025 ASCO Annual Meeting | The Manila Times

MAINZ, Germany, May 27, 2025 -- BioNTech SE (Nasdaq: BNTX, "

AI-Driven mRNA Therapeutics Market Development Accelerated by AI Integration in Drug Design Delivery and Scalable Manufacturing
)
Cambridge R&D Centre being created by BioNTech in £1bn UK spree

2,061 Shares in BioNTech SE (NASDAQ:BNTX) Acquired by GF Fund Management CO. LTD.

BioNTech SE (NASDAQ:BNTX) Stake Cut by Bank of America Corp DE

JPMorgan Chase & Co. Issues Pessimistic Forecast for BioNTech (NASDAQ:BNTX) Stock Price

BioNTech's (BNTX) "Buy" Rating Reaffirmed at HC Wainwright

BioNTech SE (NASDAQ:BNTX) Receives Average Recommendation of "Moderate Buy" from Analysts

BioNTech Strengthens UK Ties with Investment of Up to $1.33 Billion

BioNTech SE (NASDAQ:BNTX) Shares Sold by Voloridge Investment Management LLC

OMERS ADMINISTRATION Corp Purchases New Holdings in BioNTech SE (NASDAQ:BNTX)

AIM Vaccine's Next-Gen mRNA Shingles Vaccine Secures Clinical Approvals in Both PRC and U.S. ,mRNA Platform Advantages Shine Through | The Manila Times

Tema Etfs LLC Acquires New Shares in BioNTech SE (NASDAQ:BNTX)

Bank of America Securities Keeps Their Buy Rating on BioNTech SE (BNTX) | Markets Insider

Cresset Asset Management LLC Decreases Stock Holdings in BioNTech SE (NASDAQ:BNTX)

BioNTech SE (BNTX): Among the Best Growth Stocks to Buy and Hold for the Long Term

Crestline Management LP Takes $943,000 Position in BioNTech SE (NASDAQ:BNTX)

Fred Alger Management LLC Sells 35,467 Shares of BioNTech SE (NASDAQ:BNTX)

BNP Paribas Financial Markets Takes Position in BioNTech SE (NASDAQ:BNTX)

Morgan Stanley Issues Pessimistic Forecast for BioNTech (NASDAQ:BNTX) Stock Price

BioNTech (BNTX) Faces Investor Concerns Amid FDA Leadership Shift | BNTX Stock News

BioNTech (NASDAQ:BNTX) Price Target Lowered to $132.00 at Morgan Stanley

BioNTech (BNTX) Stock Declines Amid Leadership Changes and Analyst Downgrade

BioNTech (BNTX) Shares Tumble as FDA Announces Leadership Change

BioNTech (BNTX): Citigroup Maintains Rating, Lowers Price Target | BNTX Stock News

BioNTech SE (NASDAQ:BNTX) Q1 2025 Earnings Call Transcript

Baker BROS. Advisors LP Invests $5.13 Million in BioNTech SE (NASDAQ:BNTX)

BioNTech (BNTX) Target Price Lowered by Citi Analyst Amid Quarte

BioNTech SE (NASDAQ:BNTX) Shares Sold by Axa S.A.

BioNTech SE (BNTX) Q1 2025 Earnings Call Highlights: Navigating Challenges and Advancing ...

Appointments and advancements for May 6, 2025 | BioWorld

Q1 2025 Biontech SE Earnings Call Transcript

Health Care Down on Mixed Earnings - Health Care Roundup | Morningstar

BioNTech (BNTX) Price Target Cut by BofA, Buy Rating Maintained | BNTX Stock News

BioNTech (BNTX) Sees Price Target Cut Amid Upcoming Catalysts | BNTX Stock News

BioNTech SE Appoints New CFO to Drive Financial Strategy in Oncology Expansion | BNTX stock news

BioNTech SE (BNTX) Reports Q1 2025 Financial Results and Strategic Updates | BNTX stock news

BioNTech says Novartis executive Zapata-Gomez to become CFO

BioNTech (BNTX) Reveals Q1 Revenue and Advances in Strategic Focus | BNTX Stock News

BioNTech (BNTX) Reports Q1 Loss, Maintains 2025 Financial Guidance

BioNTech (BNTX) Welcomes Ramón Zapata-Gomez as New CFO

BioNTech Announces Appointment of Ramón Zapata to Management Board as Chief Financial Officer

BioNTech Announces First Quarter 2025 Financial Results and Corporate Update | The Manila Times

BioNTech Reports Smaller-Than-Expected Loss, Names New CFO

BioNTech Q1 Loss Widens, Revenues Down; Confirms FY25 Outlook

BioNTech SE Q1 25 Earnings Conference Call At 8:00 AM ET

BNTX Q1 2025 Earnings Report on 5/5/2025

BioNTech SE (NASDAQ:BNTX) Shares Purchased by CANADA LIFE ASSURANCE Co

Judge denies Pfizer and BioNTech bid to see off COVID-19 vaccine suit

BioNTech (BNTX) Involved in New Vaccine Development Initiative | BNTX Stock News

BioNTech (NASDAQ:BNTX) Shares Gap Up - Here's Why

Pfizer, BioNTech Fail to Void Alnylam's Covid-Shot Patent Claims

BioNTech (BNTX) Projected to Post Earnings on Monday